Gain control of N-methyl-D-aspartate receptor activity by receptor-like protein tyrosine phosphatase α

被引:66
|
作者
Lei, G
Xue, S
Chéry, N
Liu, Q
Xu, JD
Kwan, CL
Fu, YP
Lu, YM
Lu, MY
Harder, KW
Yu, XM
机构
[1] Univ Toronto, Fac Dent, Ctr Addict & Mental Hlth, Toronto, ON M5T 1R8, Canada
[2] Univ Toronto, Dept Psychiat, Toronto, ON M5T 1R8, Canada
[3] Univ Calgary, Fac Med, Dept Physiol & Biophys, Neurosci Res Grp, Calgary, AB T2N 4N1, Canada
[4] Univ Hlth Network, Toronto Gen Hosp, Div Cellular & Mol Biol, Toronto, ON M5G 2C4, Canada
[5] Royal Melbourne Hosp, Ludwig Inst Canc Res, Melbourne, Vic 3050, Australia
来源
EMBO JOURNAL | 2002年 / 21卷 / 12期
关键词
ligand-gated ion channels; LTP; PSD95; PTP alpha; Src;
D O I
10.1093/emboj/cdf292
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Src kinase regulation of N-methyl-D-aspartate (NMDA) subtype glutamate receptors in the central nervous system (CNS) has been found to play an important role in processes related to learning and memory, ethanol sensitivity and epilepsy. However, little is known regarding the mechanisms underlying the regulation of Src family kinase activity in the control of NMDA receptors. Here we report that the distal phosphatase domain (D2) of protein tyrosine phosphatase alpha (PTPalpha) binds to the PDZ2 domain of post-synaptic density 95 (PSD95). Thus, Src kinase, its activator (PTPalpha) and substrate (NMDA receptors) are linked by the same scaffold protein, PSD95. Removal of PTPalpha does not affect the association of Src with NMDA receptors, but turns off the constitutive regulation of NMDA receptors by the kinase. Furthermore, we found that application of the PTPalpha catalytic domains (D1 + D2) into neurones enhances NMDA receptor-mediated synaptic responses. Conversely, the blockade of endogenous PTPalpha inhibits NMDA receptor activity and the induction of long-term potentiation in hippocampal neurones. Thus, PTPalpha is a novel up-regulator of synaptic strength in the CNS.
引用
收藏
页码:2977 / 2989
页数:13
相关论文
共 50 条
  • [41] The promise of N-methyl-D-aspartate receptor antagonists in fibromyalgia
    Henriksson, KG
    Sörensen, J
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2002, 28 (02) : 343 - +
  • [42] Mutations of N-Methyl-D-Aspartate Receptor Subunits in Epilepsy
    Xing-Xing Xu
    Jian-Hong Luo
    Neuroscience Bulletin, 2018, 34 : 549 - 565
  • [43] Dopamine and N-methyl-D-aspartate receptor interactions in the neostriatum
    Cepeda, C
    Levine, MS
    DEVELOPMENTAL NEUROSCIENCE, 1998, 20 (01) : 1 - 18
  • [44] Novel pyrrolinones as N-methyl-D-aspartate receptor antagonists
    Poschenrieder, H
    Stachel, HD
    Höfner, G
    Mayer, P
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2005, 40 (04) : 391 - 400
  • [45] Deramciclane inhibits N-methyl-D-aspartate receptor function
    Kovács, I
    Szárics, É
    Skuban, N
    Kardos, J
    BRAIN RESEARCH BULLETIN, 2000, 52 (01) : 39 - 44
  • [46] The N-Methyl-D-Aspartate Receptor: Memory, Madness, and More
    Ramirez, Alejandro
    Arbuckle, Melissa R.
    BIOLOGICAL PSYCHIATRY, 2017, 82 (01) : E1 - E3
  • [47] Delayed N-methyl-D-aspartate Receptor Encephalitis Relapse
    AlShimemeri, Sohaila
    Alsaeed, Meshari
    Lai, Joshua
    Uy, Christopher
    Javidan, Manouchehr
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2020, 47 (02) : 264 - 266
  • [48] N-Methyl-D-Aspartate Receptor in Human Prostate Cancer
    M. Abdul
    N. Hoosein
    The Journal of Membrane Biology, 2005, 205 : 125 - 128
  • [49] N-methyl-D-aspartate receptor in human prostate cancer
    Abdul, M
    Hoosein, N
    JOURNAL OF MEMBRANE BIOLOGY, 2005, 205 (03): : 125 - 128
  • [50] The fyn art of N-methyl-D-aspartate receptor phosphorylation
    Sala, C
    Sheng, M
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (02) : 335 - 337